30 August 2020>: Lab/In Vitro Research
Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells
Ying Ma BE , Jun Wen BC , Jing Wang CE , Chunyan Wang DF , Yan Zhang DEF , Lili Zhao F , Jia Li A* , Xue Feng FDOI: 10.12659/MSM.924435
Med Sci Monit 2020; 26:e924435
Figure 3 Asiaticoside induced G1 phase cell cycle arrest in HCC cells. (A) The peak plot showed results of cell cycle analysis for QGY-7703 cells (red) and Bel-7402 cells (blue) after treatment with asiaticoside. (B) The percentages of the QGY-7703 cells population in G1, S, and G2/M phases after treatment with asiaticoside. (C) The percentages of the Bel-7402 cells population in G1, S, and G2/M phases after treatment with asiaticoside. (D) G1 cell cycle-related proteins alteration in QGY-7703 cells after treatment with asiaticoside. (E) G1 cell cycle-related proteins alteration in Bel-7402 cells after treatment with asiaticoside. Data are presented as mean±SD, which are representative of at least 3 independent experiments.